Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06918548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Mar 1, 2026 to Jul 1, 2026v6
  2. Primary completion date: Nov 1, 2026 to Mar 1, 2028
    • Start date: Dec 1, 2025 to Mar 1, 2026
    • Study completion date: Feb 1, 2027 to May 1, 2028
    v5
  3. Start date: Oct 1, 2025 to Dec 1, 2025v4
  4. Start date: Aug 1, 2025 to Oct 1, 2025v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating pressure injuries.
Trial Details
NCT Number NCT06918548
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions
(from sponsor)		 Pressure Injury
Related terms Pressure Ulcer
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov